详细内容
AI-enabled precision medicine
How can I help you?
With the power of AI, we now have the ability to
-
ACCELERATE
the discovery of novel targets
-
PREDICT
the effectiveness of treatments
-
IDENTIFY
potentially life-saving clinical trials
-
DIAGNOSE
multiple diseases earlier
Discover our innovative technology
- ONE AI-enabled assistant for healthcare providers and researchers
- NEXT Identify and close gaps in care
- LENS Find, access, and analyze multimodal real-world data
- ALGOS Algorithmic models connected to our assays to provide additional insight
AI-enabled assistant for healthcare providers and researchers
Identify and close gaps in care
Find, access, and analyze multimodal real-world data
Algorithmic models connected to our assays to provide additional insight
Your browser does not support the video tag.
Close Popup
Your browser does not support the video tag.
Explore Tempus
PROVIDERS
We can help physicians make more informed treatment decisions.
Your browser does not support the video tag.
LIFE SCIENCES
We can assist pharmaceutical and biotech companies with better drug development.
Your browser does not support the video tag.
PATIENTS
We can help patients find their own unique and optimal therapy options.
Your browser does not support the video tag.
Our Science
Through our scientific publications and research projects, we are accelerating and transforming personalized patient care.
Nature Biotechnology Study Reveals that Tempus’ xT Platform Increases Cancer Patients’ Personalized Therapeutic OpportunitiesExtensive molecular profiling combined with clinical data identifies targeted therapies and clinical trials for a large proportion of cancer patients, and paired tumor/normal plus transcriptome sequencing outperforms tumor-only DNA panel testing. 
A Pan-cancer Organoid Platform for Precision MedicineShowcasing a robust pan-cancer tumor organoid (TO) platform, revealing genomic/transcriptome fidelity of TO culture from >1,000 patients. We demonstrate a neural-network-based high-throughput approach for label-free, light-microscopy-based drug assays capable of predicting patient-specific heterogeneity in drug responses with applicability across solid cancers. 
Validation of a Liquid Biopsy Assay with Molecular and Clinical Profiling of Circulating Tumor DNAActionable variants would have been missed if only solid tumor or liquid biopsy tests were performed. Thus, we believe that liquid biopsies provide value to patients when used in combination with standard tissue genotyping.
Improving patient care through high quality testing, clinical trial matching, and deep research data that powers scientific discovery
~65% of all Academic Medical Centers in the US are connected to Tempus
50%+ of oncologists in the US connected to Tempus through sequencing, clinical trial matching, and research-enabled partnerships
95% of the top 20 pharma oncology companies partner with Tempus
250+ biopharma partnerships
40,000,000+ de-identified research records to power scientific discovery to improve patient outcomes
40,000+ patients have been identified for potential enrollment into clinical trials in our network
350+ petabytes of data
Tempus Announces the Acquisition of Paige
Tempus has acquired Paige, an AI company specializing in digital pathology, in an effort to grow its dataset, expand its experienced technical team, and establish a strong footprint in digital pathology.
Northwestern Medicine Becomes First Health System to Integrate Tempus’ Generative AI Co-Pilot, David, into its EHR Platform
Northwestern Medicine is the first health system to integrate David, Tempus’ generative-AI clinical co-pilot, within its electronic health record (EHR) platform for its clinical care team.
Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-Low EF Software
Tempus received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Tempus ECG-Low EF (ejection fraction) software, which uses AI to identify certain patients who may have a low left ventricular ejection fraction (LVEF).
Close Popup
Your browser does not support the video tag.
This is AI-enabled precision medicine
This is the future of healthcare.
*
I AM
Select...Provider or Health SystemBiopharmaPatientOther
reCAPTCHA
Recaptcha requires verification.
protected by reCAPTCHA
reCAPTCHA is changing its terms of service. Take action.
This site is protected by reCAPTCHA and the Google
Privacy Policy and Terms of Service apply.
Submit
Thank you for contacting Tempus. We will respond shortly.
Marketo Forms 2 Cross Domain request proxy frame